About
Brad L. Tade served as Executive Vice President, Chief Financial Officer and Treasurer from July 2024 until February 25, 2026, when he retired and transitioned to a consulting role expected to run through July 2026. He joined ADMA in June 2023 as Vice President, Financial Operations and previously held finance leadership roles at PCI Pharma Services, Baxter International and Becton Dickinson. He holds a B.S. in Finance from California State University, Long Beach and a master's in Organizational Leadership from Gonzaga University.
Roles
Adma Biologics, Inc.
Former Executive Vice President and Chief Financial Officer · Current role
2023–present
PCI Pharma Services
Vice President Finance, Commercial Packaging Technology
March 2023-June 2023
PCI Pharma Services
Vice President Finance, Development and Manufacturing
August 2022-March 2023
Baxter International Inc.
Vice President Finance, Operations & Quality
May 2021-July 2022
Becton Dickinson
Vice President, Operations Finance · Based in Switzerland.
November 2016-May 2021
Fixed Compensation
FY 2025
All other compensation
$73,645
Performance Compensation
Data from FY 2025
Cash incentive
Non-equity incentive plan (annual bonus)
$250,000
Stock awards
Stock awards (RSUs)
$999,988
Also at Adma Biologics, Inc.